rs41321052
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 8P and 1B. PM1PM2PP3_StrongBP6
The NM_000517.6(HBA2):c.307A>C(p.Ser103Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,458,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.
Frequency
Consequence
NM_000517.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia spectrumInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- erythrocytosis, familial, 7Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hemoglobin M diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hb Bart's hydrops fetalisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin H diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Heinz body anemiaInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- methemoglobinemia, alpha typeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HBA2 | NM_000517.6 | c.307A>C | p.Ser103Arg | missense_variant | Exon 3 of 3 | ENST00000251595.11 | NP_000508.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HBA2 | ENST00000251595.11 | c.307A>C | p.Ser103Arg | missense_variant | Exon 3 of 3 | 1 | NM_000517.6 | ENSP00000251595.6 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD2 exomes AF: 0.00000806 AC: 2AN: 248256 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1458060Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 725166 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
The frequency of this variant in the general population, 0.0000081 (2/248256 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. In vitro studies have shown that Hb Manitoba I is mildly unstable and has reduced dissociation (PMID: 7803274 (1994), 5452728 (1970)). Individuals heterozygous for this variant have a normal clinical presentation, with Hb Manitoba I accounting for 19% of total hemoglobin (PMID: 11791879 (2001), 7803274 (1994), 6547932 (1984), 5452728 (1970)). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is deleterious or benign. Based on the available information, we are unable to determine the clinical significance of this variant. -
- -
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693823:Erythrocytosis, familial, 7 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at